{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:10:20Z","timestamp":1772428220317,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bpg.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T23:54:12Z","timestamp":1335311652000},"page":"163-172","source":"Crossref","is-referenced-by-count":19,"title":["Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice"],"prefix":"10.1016","volume":"26","author":[{"given":"En-ling","family":"Leung Ki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis K.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2012.01.006_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1185\/030079907X162656","article-title":"Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment","volume":"23","author":"Lanas","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpg.2012.01.006_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrgastro.2011.97","article-title":"Gastrointestinal effects of aspirin","volume":"8","author":"Sostres","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.01.006_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14740338.2010.507629","article-title":"Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice","volume":"10","author":"Lanas","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bpg.2012.01.006_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00002018-200528040-00002","article-title":"NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management","volume":"28","author":"Chan","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.bpg.2012.01.006_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1443-9573.2005.00192.x","article-title":"Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?","volume":"6","author":"Chan","year":"2005","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.bpg.2012.01.006_bib6","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.3748\/wjg.v11.i25.3811","article-title":"Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users","volume":"11","author":"Papatheodoridis","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1523-5378.2010.00762.x","article-title":"Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers","volume":"15","author":"Venerito","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2012.01.006_bib8","first-page":"67","article-title":"Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals","volume":"57","author":"Brzozowski","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.bpg.2012.01.006_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJM200103293441304","article-title":"Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen","volume":"344","author":"Chan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.006_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00535-011-0385-y","article-title":"Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy","volume":"46","author":"Iijima","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.01.006_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gut.51.3.344","article-title":"Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users","volume":"51","author":"Hawkey","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.01.006_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2036.2009.04133.x","article-title":"Predictors of gastroduodenal erosions in patients taking low-dose aspirin","volume":"31","author":"Hart","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.2010.207662","article-title":"Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori","volume":"60","author":"Hagiwara","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.01.006_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1365-2036.1998.00434.x","article-title":"Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study","volume":"12","author":"Chan","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0016-5085(98)70474-3","article-title":"Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans","volume":"114","author":"Konturek","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.006_bib17","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/S0016-5085(10)61109-2","article-title":"Effect of Helicobacter pylori infection on the phenomenon of gastric mucosal adaptation to repetitive aspirin insult in mongolian gerbils. Role of reactive oxygen metabolites and proinflammatory cytokines (abstr)","volume":"138","author":"Pajdo","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.006_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2010.04415.x","article-title":"Systematic review: H. pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin","volume":"32","author":"Fletcher","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2036.2002.01230.x","article-title":"Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin","volume":"16","author":"Lanas","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2036.2002.01197.x","article-title":"Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding","volume":"16","author":"Stack","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02649.x","article-title":"Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin","volume":"22","author":"Yeoman","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa012877","article-title":"Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use","volume":"346","author":"Lai","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.01.006_bib23","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0016-5085(11)60703-8","article-title":"Effect of Helicobacter pylori eradication on the long-term incidence of recurrent ulcer bleeding in high-tisk aspirin users: a 10-year prospective cohort study (abstr)","volume":"140","author":"Chan","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.01.006_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1440-1746.2004.03374.x","article-title":"Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury","volume":"19","author":"Giral","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.01.006_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Rol of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.01.006_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000321813","article-title":"Gastrointestinal bleeding after percutaneous coronary intervention","volume":"83","author":"Tanigawa","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2012.01.006_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"Lanas","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib29","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/ajg.2010.445","volume":"105","author":"Abraham","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2036.2001.00874.x","article-title":"Helicobacter pylori screening for individuals requiring chronic NSAID therapy: a decision analysis","volume":"15","author":"Scheiman","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11510","article-title":"Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding","volume":"11","author":"Leontiadis","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bpg.2012.01.006_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2036.2006.02810.x","article-title":"Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey","volume":"23","author":"Chey","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.01.006_bib33","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.01.006_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2009.00738.x","article-title":"Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition","volume":"15","author":"Asaka","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.bpg.2012.01.006_bib36","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1111\/j.1572-0241.2008.02216.x","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"103","author":"Bhatt","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.01.006_bib37","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691812000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T18:10:38Z","timestamp":1561659038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691812000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1521691812000078"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2012.01.006","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}